Chengdu Kanghong Pharmaceutical Group Co., Ltd (SHE: 002773)

Chengdu Kanghong Pharmaceutical Group Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Market Capitalization	17,531	16,955	14,426	18,711	44,373	32,296
Market Cap Growth	35.06%	17.53%	-22.90%	-57.83%	37.39%	40.74%
Enterprise Value	11,991	12,473	11,281	15,524	42,323	30,280
Last Close Price	19.06	18.13	15.32	19.73	46.48	35.45
PE Ratio	14.66	16.23	16.09	44.44	-	44.97
Forward PE	14.01	12.75	12.75	17.93	44.74	33.57
PS Ratio	4.00	4.28	4.26	5.19	13.46	9.91
PB Ratio	2.08	2.17	2.09	3.06	7.71	6.99
P/TBV Ratio	2.42	2.26	2.20	3.22	8.46	7.90
P/FCF Ratio	13.34	15.71	25.31	-	-	-
P/OCF Ratio	13.44	13.92	15.59	37.87	162.35	39.77
EV/Sales Ratio	2.74	3.15	3.33	4.31	12.84	9.30
EV/EBITDA Ratio	7.88	9.44	11.05	28.00	-	38.64
EV/EBIT Ratio	9.59	11.33	13.05	38.14	-	43.84
EV/FCF Ratio	9.12	11.55	19.79	-	-	-
Debt / Equity Ratio	0.00	0.00	0.00	0.00	-	0.00
Debt / EBITDA Ratio	0.00	0.00	0.00	0.01	-	0.00
Debt / FCF Ratio	0.00	0.00	0.01	-	-	-
Asset Turnover	0.50	0.49	0.46	0.52	0.51	0.59
Inventory Turnover	1.17	1.19	1.25	1.33	1.31	1.02
Quick Ratio	7.80	7.47	5.58	5.08	3.78	3.66
Current Ratio	8.43	8.11	6.10	5.54	4.04	4.05
Return on Equity (ROE)	14.72%	14.01%	13.31%	7.10%	-5.20%	16.50%
Return on Assets (ROA)	8.88%	8.47%	7.36%	3.65%	-6.31%	7.83%
Return on Capital (ROIC)	9.75%	9.35%	8.30%	4.29%	-7.80%	9.92%
Earnings Yield	6.82%	6.16%	6.22%	2.25%	-0.61%	2.22%
FCF Yield	7.50%	6.37%	3.95%	-0.40%	-0.79%	-0.47%
Dividend Yield	1.99%	2.10%	0.98%	0.51%	0.22%	0.79%
Payout Ratio	29.28%	13.20%	10.25%	21.84%	-	26.16%
Buyback Yield / Dilution	-0.56%	-0.16%	0.05%	-5.16%	0.34%	-0.55%
Total Shareholder Return	1.43%	1.93%	1.03%	-4.65%	0.56%	0.24%

Source: S&P Capital IQ. Standard template. Financial Sources.